Tag - cancer

 
 

CANCER

Japan Times
WORLD / Science & Health
Jul 14, 2023
Aspartame ‘possibly’ carcinogenic, yet safe at common-use levels, WHO says
A chemical-based sweetener that is hundreds of times sweeter than sugar, aspartame is packaged and sold under names such as Equal.
Japan Times
JAPAN / Science & Health
Jun 27, 2023
Rare cancer drug trials to go online in Japan
The project is aimed at making it easier for patients in the countryside to join clinical trials and reduce their economic burden.
Japan Times
COMMENTARY / World
Jun 23, 2023
Eradicate breast cancer? The hunt for a vaccine looks promising
Women in the future may soon be able to get a series of shots that teach their immune systems how to quash breast cancer before it becomes a problem.
Japan Times
BUSINESS / Companies
Jun 7, 2023
AstraZeneca’s Japan partner to go solo on future cancer drugs
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.
Japan Times
WORLD / Science & Health
Jun 6, 2023
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck-Moderna data
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
Japan Times
JAPAN / Science & Health
Jun 4, 2023
Japan cancer center eager to raise awareness about cervical cancer
Some 11,000 people a year are diagnosed with cervical cancer in Japan, and about 3,000 die of the disease annually, according to a new report.
Japan Times
WORLD / Science & Health
Jun 3, 2023
Breast cancer drug shown to reduce recurrence risk
Even when the disease is caught early, breast cancer recurrence is relatively common — and for survivors, the prospect can be daunting.
Japan Times
WORLD
Jun 3, 2023
Three makers of ‘forever chemicals’ settle water lawsuits in U.S.
The companies — Chemours, DuPont and Corteva — said they had reached an agreement in principle to set up a $1.19 billion fund to help remove toxic PFAS from drinking water systems.
Japan Times
WORLD / Science & Health
May 10, 2023
Mammograms should start at 40, U.S. task force says
Breast cancer is the second-most common cancer and the second-most common cause of cancer death for women in the United States.
Japan Times
COMMENTARY / World
Apr 21, 2023
Cancer vaccine hunt makes progress, finally
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
WORLD / Science & Health
Apr 17, 2023
Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer
The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer's return.
Japan Times
JAPAN
Apr 7, 2023
Japan adds new HPV vaccine to routine inoculation program
According to the health ministry, most cervical cancer cases can be attributed to HPV infection through sexual intercourse, with many cases occurring at a young age.
Japan Times
JAPAN / Science & Health
Mar 14, 2023
Low alcohol tolerance increases chance of hard-to-cure stomach cancer in East Asians
A Japanese study has found that certain genomic abnormalities specifically related to alcohol consumption are linked to the onset of “diffuse-type” stomach cancer.
Japan Times
WORLD / Politics
Mar 4, 2023
Biden had skin cancer removed, as doctor says no more treatment needed
White House physician Kevin O'Connor said that basal cell carcinoma lesions such as the one found on the U.S. president do not tend to spread or metastasize.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
ASIA PACIFIC
Dec 24, 2022
Sri Lanka's cancer patients struggle amid economic chaos
Hospitals across Sri Lanka are struggling to contend with severe drug shortages, which have worsened over the last eight months amid an economic crisis.
Japan Times
COMMENTARY / World
Dec 21, 2022
Another Crispr first: New treatment wipes out teen's cancer
Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.
Japan Times
BUSINESS / Companies
Nov 30, 2022
Japanese biotech firm uses tiny worms in test for pancreatic cancer
The creatures, a species of nematodes known scientifically as C. elegans, have olfactory senses much more powerful than dogs, the firm says, and they follow their nose toward cancer cells.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?